Filing Details
- Accession Number:
- 0001968202-24-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-16 16:15:32
- Reporting Period:
- 2024-02-14
- Accepted Time:
- 2024-02-16 16:15:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1411984 | P Daniel Plew Van | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp & General Mgr, Industrial | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-14 | 439 | $937.94 | 30,373 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 226 | $938.13 | 30,147 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 750 | $939.60 | 29,397 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 4,261 | $940.44 | 25,136 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 275 | $941.41 | 24,861 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 2,691 | $943.51 | 22,170 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 620 | $944.30 | 21,550 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 95 | $945.81 | 21,455 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 240 | $947.81 | 21,215 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 150 | $948.70 | 21,065 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 112 | $949.07 | 20,953 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 375 | $950.45 | 20,578 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-02-14 | 200 | $951.77 | 20,378 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 12,376 | Indirect | 2023 GRAT |
Common Stock | 1,084 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.